Use of non-vitamin K antagonists oral anticoagulants in atrial fibrillation patients on dialysis

BackgroundNon-vitamin K antagonist oral anticoagulants (NOACs) showed a benefit-risk profile superior to that of warfarin in atrial fibrillation (AF) patients with mild to moderate chronic kidney disease. However, the effectiveness and safety of NOACs in AF patients with end-stage renal disease (ESR...

Full description

Bibliographic Details
Published in:Frontiers in Cardiovascular Medicine
Main Authors: Wenhao Li, Yanxia Zhou, Siqi Chen, Dewang Zeng, Haidong Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Subjects:
non-vitamin K antagonist oral anticoagulants
warfarin
atrial fibrillation
dialysis
meta-analysis
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.1005742/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2022.1005742/full

Similar Items